Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
06:00:00 25/04/26 am AEST
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 06/05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 29/04 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.9B 3.65B 3.34B 6.26B 435B 6.35B 43.08B 16.8B 219B 17.08B 16.71B 723B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.02B 3.77B 3.45B 6.47B 450B 6.56B 44.49B 17.35B 226B 17.64B 17.26B 747B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +1.05% | ||
| Current year | +1.76% |
| Current year | 14.2 | 14.5 | |
| 1 year | 7.4 | 14.5 | |
| 3 years | 5.51 | 14.57 | |
| 5 years | 5.51 | 14.57 | |
| 10 years | 4.41 | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/1/26 | Fiscal year | Chief Executive Officer | 225,000 | 0.0727% | ||
| 2/1/26 | Tax | General Counsel | 43,109 | 0.0139% | ||
| 2/1/26 | Tax | Executive/Senior Manager | 30,007 | 0.0097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.21% | -.--% | +90.66% | +14.82% | 4.55B | ||
| +1.09% | +5.26% | +4.44% | +26.03% | 51.61B | ||
| -1.07% | +2.82% | +474.18% | +601.24% | 44.89B | ||
| +1.47% | +9.79% | +40.15% | +21.21% | 42.77B | ||
| +1.44% | +7.77% | +19.27% | +90.94% | 42.58B | ||
| -0.93% | -4.33% | +17.87% | +51.96% | 31.82B | ||
| +1.32% | +7.30% | +36.93% | +152.36% | 17.33B | ||
| -0.60% | +1.93% | - | - | 16.63B | ||
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | ||
| +1.28% | +5.41% | +91.01% | +46.93% | 14.09B | ||
| Average | +0.42% | +4.01% | +86.85% | +115.66% | 28.1B | |
| Weighted average by Cap. | +0.48% | +4.64% | +102.36% | +146.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 453M 423M 388M 727M 50.55B 737M 5B 1.95B 25.39B 1.98B 1.94B 83.99B | 634M 543M 508M 465M 873M 60.68B 885M 6.01B 2.34B 30.48B 2.38B 2.33B 101B |
| Net income | -56.11M -48.06M -44.97M -41.16M -77.25M -5.37B -78.27M -531M -207M -2.7B -211M -206M -8.92B | -27.11M -23.22M -21.73M -19.89M -37.33M -2.59B -37.82M -257M -100M -1.3B -102M -99.58M -4.31B |
| Net Debt | 194M 166M 155M 142M 267M 18.53B 270M 1.83B 715M 9.31B 727M 711M 30.79B | 149M 127M 119M 109M 205M 14.24B 208M 1.41B 550M 7.15B 559M 547M 23.66B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions

















